S&P 500, Nasdaq end at record highs on vaccine optimism

THE S&P 500 and Nasdaq Composite indexes closed at record highs on Tuesday, with investors betting a COVID-19 vaccine will be available soon, and more confident about a speedy economic recovery following upbeat Chinese factory data.

Investors stayed focused on updates about a handful of vaccine candidates and the start of global shipments as drug makers submit paperwork for regulatory approvals.

The Dow Jones Industrial Average rose 0.63% to end at 29,823.92 points, while the S&P 500 gained 1.13% to 3,662.44. The Nasdaq Composite climbed 1.28% to 12,355.11.

All three main stock indexes gained more than 10% in November.

Pfizer Inc jumped almost 3% after the drug maker and Germany’s BioNTech SE sought emergency approval of their vaccine candidate from the European regulator.

The partners are neck-and-neck with rival Moderna Inc which also applied for emergency approval from the European regulator. Its stock tumbled nearly 8% from a record high the day before.

“There is this optimism about what it means as we see news around vaccines emerge,” said Bill Northey, senior investment director at US Bank Wealth Management in Minneapolis.

“As we look toward a health solution, we could be sitting on a coiled spring of economic activity, but it could take a while for it to be unleashed.”

Earlier in the day, global equities got a boost from data that showed China’s factory activity in November increased at its fastest pace in a decade. Several other countries also reported sharp upticks in factory activity.

US data showed a recovery in manufacturing activity lost momentum in November.

All 11 S&P 500 sector indexes rose, with communication services up 2% and the leading gains.

On Tuesday, investors also focused on remarks by US Treasury Secretary Steve Mnuchin and Federal Reserve Chair Jerome Powell at the Senate Banking Committee where they agreed on the need for more aid for small businesses.

Meanwhile, a bipartisan group of US lawmakers unveiled a US$908 bil COVID-19 relief bill aimed at breaking a months-long deadlock between Democrats and Republicans over new emergency assistance for small businesses, unemployed people, airlines and other industries during the pandemic.

Advancing issues outnumbered declining ones on the NYSE by a 2.45-to-1 ratio; on Nasdaq, a 1.38-to-1 ratio favoured advancers.

The S&P 500 posted 48 new 52-week highs and no new lows; the Nasdaq Composite recorded 185 new highs and 8 new lows.

Volume on US exchanges was 13.5 billion shares compared with the 11.5 billion average over the last 20 trading days. – Dec 2, 2020

Share on facebook
Share on twitter
Share on whatsapp
Share on email

Subscribe and get top news delivered to your Inbox everyday for FREE